rs3025058 — MMP3 5A/6A

Promoter polymorphism affecting MMP3 enzyme expression levels, influencing cartilage degradation and connective tissue remodeling

See your personal result for MMP3

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Matrix Remodeler — How a Promoter Variant Shapes Your Joints and Arteries

Matrix metalloproteinase-3 (MMP-3), also called stromelysin-1, is one of the body's primary enzymes for breaking down the extracellular matrix — the structural scaffolding that holds tissues together. MMP-3 degrades collagen types II, III, IV, IX, and X, along with proteoglycans, fibronectin, laminin, and elastin11 MMP-3 degrades collagen types II, III, IV, IX, and X, along with proteoglycans, fibronectin, laminin, and elastin
These proteins form the framework of cartilage, tendons, blood vessel walls, and other connective tissues. The rs3025058 polymorphism, a simple insertion or deletion of a single adenosine base in the gene's promoter region at position -1612, profoundly affects how much MMP-3 your cells produce.

The variant is known as the 5A/6A polymorphism because one version contains a run of 5 adenosines (the 5A allele, higher activity) while the other has 6 adenosines (the 6A allele, lower activity). In 23andMe raw data, this appears as T's on the complementary strand: TT corresponds to 5A/5A (highest MMP-3 expression), CT to 5A/6A (intermediate), and CC to 6A/6A (lowest expression).

The Mechanism

This is a classic example of a regulatory variant — the DNA sequence change doesn't alter the MMP-3 protein itself, but rather controls the dimmer switch determining how much enzyme gets made. The 5A allele shows 2-4 fold higher promoter activity and gene expression compared to the 6A allele22 The 5A allele shows 2-4 fold higher promoter activity and gene expression compared to the 6A allele
Studies in macrophages, smooth muscle cells, and fibroblasts all demonstrate this functional difference. The mechanism involves differential binding of the transcription factor NFκB: the NFκB p50 and p65 subunits bind more strongly to the 5A allele than the 6A allele, particularly during inflammatory conditions33 the NFκB p50 and p65 subunits bind more strongly to the 5A allele than the 6A allele, particularly during inflammatory conditions
This allele-specific transcriptional regulation is augmented when cells are activated.

The Evidence

The clinical consequences of this promoter polymorphism depend heavily on context — which tissue is affected, what type of stress it's under, and even ancestry. The most robust associations emerge in musculoskeletal conditions:

Osteoarthritis and Joint Degeneration: A meta-analysis in Chinese men found multiple MMP-3 SNPs associated with increased osteoarthritis risk44 A meta-analysis in Chinese men found multiple MMP-3 SNPs associated with increased osteoarthritis risk
rs3025058 was among the variants showing significant association. The biology makes sense: excessive MMP-3 activity accelerates cartilage breakdown, while insufficient activity impairs the normal remodeling needed for joint health. Studies in rheumatoid arthritis patients found those homozygous for the 6A allele had significantly more radiographic damage and higher serum MMP-3 levels55 Studies in rheumatoid arthritis patients found those homozygous for the 6A allele had significantly more radiographic damage and higher serum MMP-3 levels
The 6A/6A genotype was associated with a Larsen score of 109.8 vs 91.1 for other genotypes.

Tendon and Ligament Injury: A 2022 meta-analysis of 2,871 cases and 4,497 controls found rs3025058 associated with increased tendon-ligament injury risk in Caucasians and Brazilians66 A 2022 meta-analysis of 2,871 cases and 4,497 controls found rs3025058 associated with increased tendon-ligament injury risk in Caucasians and Brazilians
This included Achilles tendinopathy, ACL rupture, tennis elbow, and rotator cuff tears. MMP-3 normally maintains healthy collagen turnover in tendons, but dysregulated expression — whether too high or too low — can predispose to injury under mechanical stress.

Cardiovascular Disease: The picture is more complex here, with ancestry-specific effects. In a large meta-analysis combining 15 studies with 10,061 cases and 8,048 controls, the 5A allele showed reduced coronary disease risk in Europeans (OR 0.87) but increased risk in East Asian populations77 In a large meta-analysis combining 15 studies with 10,061 cases and 8,048 controls, the 5A allele showed reduced coronary disease risk in Europeans (OR 0.87) but increased risk in East Asian populations
The overall analysis found no consistent association. However, within European cohorts, the 6A/6A genotype was associated with greater numbers of coronary arteries with significant stenosis (OR 1.52), while the 5A allele carriers showed increased myocardial infarction risk (OR 1.78-2.02)88 the 6A/6A genotype was associated with greater numbers of coronary arteries with significant stenosis (OR 1.52), while the 5A allele carriers showed increased myocardial infarction risk (OR 1.78-2.02)
This suggests different disease processes: stable but bulky plaques in 6A/6A individuals vs unstable rupture-prone plaques in 5A carriers.

Other Associations: The variant has also been linked to colonic diverticulosis99 colonic diverticulosis
5A/5A genotype nearly twice as common in patients vs controls, abdominal aortic aneurysm1010 abdominal aortic aneurysm
5A allele associated with increased risk, and earlier age at Alzheimer's disease onset in 5A/6A heterozygotes1111 earlier age at Alzheimer's disease onset in 5A/6A heterozygotes.

Practical Implications

Your MMP-3 genotype interacts with mechanical stress, inflammation, and aging to influence connective tissue health. The "optimal" genotype likely depends on your specific risk factors and tissue demands. High MMP-3 expression (TT/5A5A) accelerates matrix turnover — beneficial when you need tissue remodeling, potentially harmful when sustained inflammation drives excessive degradation. Low MMP-3 expression (CC/6A6A) preserves existing matrix but may impair adaptation to mechanical demands or clearance of damaged proteins.

For joint health, this means paying attention to the balance between loading and recovery. MMP-3 expression is activated by inflammatory cytokines like IL-1 and TNF-α1212 MMP-3 expression is activated by inflammatory cytokines like IL-1 and TNF-α
Chronic low-grade inflammation amplifies genotype effects. If you carry genotypes associated with joint degeneration in your ancestry group, anti-inflammatory lifestyle factors become especially important: maintaining healthy body weight to reduce joint loading, omega-3 fatty acids to dampen inflammatory signaling, and strength training to build muscular support around vulnerable joints.

For tendon injury risk, progressive loading becomes critical. If you're ramping up training volume or starting a new athletic activity, the principle of gradual adaptation matters more than for those with protective genotypes. Allow adequate recovery time between high-stress sessions, and prioritize technique over intensity — proper movement patterns distribute forces more evenly across connective tissues.

Interactions

MMP-3 works within a broader network of matrix metalloproteinases and their inhibitors. Other MMP-3 gene variants (rs679620, rs650108, rs520540, rs602128) may interact with rs3025058 to influence net enzyme activity and tissue remodeling capacity. Studies in ACL rupture found that MMP3 rs679620 may interact with MMP10 rs485055, MMP1 rs1799750, and MMP12 rs2276109 to collectively contribute to injury susceptibility1313 Studies in ACL rupture found that MMP3 rs679620 may interact with MMP10 rs485055, MMP1 rs1799750, and MMP12 rs2276109 to collectively contribute to injury susceptibility
These multi-locus effects suggest pathway-level interactions. The balance between MMPs and tissue inhibitors of metalloproteinases (TIMPs) ultimately determines whether you're in a net catabolic (breakdown) or anabolic (building) state in your connective tissues.

Genotype Interpretations

What each possible genotype means for this variant.

CT Intermediate MMP-3 Expression Intermediate

You have intermediate MMP-3 enzyme production, balancing matrix breakdown and preservation

You carry one copy of each allele (5A and 6A, shown as CT in 23andMe data), giving you moderate MMP-3 enzyme production — higher than 6A/6A homozygotes but lower than 5A/5A. This is the most common genotype in most populations, found in about 45-50% of Europeans and 20-30% of East Asians. You have a balanced profile for extracellular matrix turnover.

This intermediate status means you're less likely to experience the extremes seen with homozygous genotypes. You probably have adequate matrix remodeling capacity for most normal tissue stresses, without the accelerated degradation that can accompany very high MMP-3 levels. One study in Alzheimer's patients found heterozygotes had slightly earlier disease onset compared to homozygotes, though the clinical significance remains unclear.

CC Low MMP-3 Expression Decreased

Your cells produce less MMP-3 enzyme from this gene, slowing extracellular matrix turnover

You carry two copies of the 6A allele (shown as CC in 23andMe data), which results in the lowest level of MMP-3 enzyme production. This means your cells break down extracellular matrix components more slowly than average. About 20-30% of people of European descent share this genotype, while it's more common in East Asian populations (around 70-80%). The 6A allele has lower promoter activity because the extra adenosine base disrupts optimal binding of transcription factors that activate the gene.

Lower MMP-3 activity can be protective in some contexts — you may be less prone to the rapid cartilage degradation seen in osteoarthritis, and less likely to develop unstable atherosclerotic plaques that rupture and cause heart attacks. However, the downside is impaired tissue remodeling capacity and possible accumulation of damaged matrix proteins. In rheumatoid arthritis patients, this genotype has been associated with more severe radiographic joint damage, possibly because the slower turnover prevents clearance of inflammatory debris.

TT High MMP-3 Expression High

Your cells produce high levels of MMP-3 enzyme, accelerating extracellular matrix breakdown

The 5A allele's higher activity stems from enhanced binding of the NFκB transcription factor to the MMP-3 promoter. During inflammatory conditions — whether from acute injury, chronic disease, or systemic inflammation — NFκB activation further amplifies the difference between 5A and 6A alleles. This means your genotype's effects are magnified in the presence of inflammation.

The association with cardiovascular outcomes differs by ancestry | In East Asian populations, the 5A allele shows increased coronary disease risk, while in European populations the relationship is more complex. Meta-analyses suggest the 5A allele may predispose to myocardial infarction (OR 1.21-2.02) through plaque instability, even if you don't develop extensive stenosis. For hemodialysis patients, the 5A/5A genotype showed the lowest cardiovascular survival over 7 years | This highlights the importance of managing inflammation in high-risk populations.